![]() |
市场调查报告书
商品编码
1734846
低温运输包装冷媒市场预测(至 2032 年):按类型、包装类型、应用、最终用户和地区进行的全球分析Cold Chain Packaging Refrigerants Market Forecasts to 2032 - Global Analysis By Type (Gel Packs, Ice Packs, Dry Ice, Liquid Nitrogen, Phase Change Materials, Eutectic Plates, and Other Types), Packaging Type, Application, End Users and By Geography |
根据 Stratistics MRC 的数据,全球低温运输包装冷媒市场预计在 2025 年达到 17.2 亿美元,到 2032 年将达到 33.8 亿美元,预测期内的复合年增长率为 10.1%。
低温运输包装冷媒是用于在运输和储存对温度敏感的产品(例如药品、生技药品和易生鲜食品)过程中保持低温的专用材料。这些冷媒可以是凝胶包、干冰或相变材料,透过防止温度波动来帮助维持产品完整性。它们是低温运输物流的重要组成部分,确保符合法规要求,并在受控温度条件下最大限度地减少远距或长期运输过程中的损坏。
根据 Pelican 的 2020 年生物製药低温运输物流永续性研究,约有 38% 的生物製药公司使用可重复使用的租赁货柜,其中 25% 的公司考虑在 2019 年这样做。
对温度敏感药品的需求不断增加
製药业越来越依赖低温运输包装冷媒来维持对温度敏感的药物的功效。随着疫苗、生技药品和特种药物需求的不断增长,保持严格的温度控制对于防止劣化至关重要。先进的製冷技术确保了安全的运输和储存,从而支持了生技药品和个人化药物的成长。政府强制执行的严格温度维持法规进一步推动了市场需求。医药供应链的扩张,尤其是在新兴国家,正在推动有效冷冻解决方案的采用。
监理合规的复杂性
严格的法律规范规范着对温度敏感的医药产品的运输和储存,这给製造商带来了合规挑战。企业必须遵守美国食品药物管理局 (FDA) 和世界卫生组织 (WHO) 等组织制定的严格全球标准,通常需要大量的文件和检验。适应不同地区的法规会增加业务的复杂性,并影响物流和供应链的效率。违规可能导致产品召回、法律后果和财务损失,从而阻碍市场成长。
电子商务和线上杂货服务的全球扩张
消费者越来越多地订购生鲜产品,例如冷冻食品、乳製品和生鲜食品,这需要在运输过程中提供有效的冷却解决方案。零售商和物流供应商正在采用先进的冷媒,以确保最后一哩配送过程中的产品品质和安全。直接面向消费者的药品运输量的增加进一步推动了医疗物流中冷媒的应用。包装材料和冷媒的技术进步为电子商务的全球扩张提供了永续、高效的冷却方法。
供应链中断和温度异常
运输延误、劳动力短缺和地缘政治紧张局势使温控运输面临风险,导致产品损失。不当冷却或不可预见的环境条件导致的温度升高,威胁药品和生鲜产品的品质。原料成本和能源消耗的上升也对冷媒市场的稳定性构成挑战。企业必须投资强大的监控系统和预测分析,以降低这些风险并确保合规性。
COVID-19的影响
新冠疫情对低温运输包装冷媒市场产生了重大影响,重塑了物流和供应链的优先事项。全球疫苗的紧急推广推动了对高效冷媒解决方案的需求,以维持药品在运输过程中的稳定性。供应链中断,包括劳动力短缺和物流限制,影响了冷媒的供应和定价。疫情过后,对远端医疗和药品直送服务的依赖度不断提高,持续推动需求成长。
凝胶包市场预计将成为预测期内最大的市场
凝胶包因其多功能性和高效的保温性能,预计将在预测期内占据最大的市场占有率。凝胶包可为药品、食品和生物样本提供稳定的冷却,使其成为低温运输物流的首选。其易用性和再生性提高了永续性,并降低了整体包装成本。相变材料的进步进一步提升了凝胶包的性能,优化了冷却时间和稳定性。
预计诊断实验室部门在预测期内将以最高的复合年增长率成长。
由于对温度敏感诊断材料的需求不断增长,预计诊断实验室领域将在预测期内实现最高增长。血液样本、试剂和检测套组需要严格的温度控制,以在运输过程中保持其完整性。感染疾病的爆发和诊断技术的进步刺激了对专用冰袋解决方案的需求。全球实验室网路和医疗检测设施的扩张进一步推动了市场的成长。
由于製药和食品行业的快速扩张,预计亚太地区将在预测期内占据最大的市场占有率。中国、印度和日本等国家正大力投资低温运输基础设施,以满足日益增长的医疗保健和零售需求。消费者对新鲜和冷冻食品的偏好日益增长,推动了高效製冷解决方案的普及。政府法规要求对药品进行严格的温度控制,这将进一步推动市场成长。
预计北美地区在预测期内将实现最高的复合年增长率,这得益于该地区先进的医疗保健和食品供应链基础设施。严格的药品储存和运输法规正在推动冷媒的广泛应用。冷媒材料和监控系统的技术创新正在提高低温运输的效率和可靠性。不断扩张的电商业务,尤其是在食品杂货和药品配送领域的电商业务,正在推动市场成长。
According to Stratistics MRC, the Global Cold Chain Packaging Refrigerants Market is accounted for $1.72 billion in 2025 and is expected to reach $3.38 billion by 2032 growing at a CAGR of 10.1% during the forecast period. Cold chain packaging refrigerants are specialized materials used to maintain low temperatures during the transportation and storage of temperature-sensitive products, such as pharmaceuticals, biologics, and perishable foods. These refrigerants-such as gel packs, dry ice, and phase change materials-help preserve product integrity by preventing temperature fluctuations. They are critical components of cold chain logistics, ensuring regulatory compliance and minimizing spoilage during long-distance or extended-duration shipments under controlled thermal conditions.
According to Pelican's 2020 Biopharma Cold Chain Logistics Sustainability Survey, around 38% of biopharma companies had used reusable rental containers, while 25% explored them in 2019.
Rising demand for temperature-sensitive pharmaceuticals
The pharmaceutical industry increasingly relies on cold chain packaging refrigerants to preserve the efficacy of temperature-sensitive medications. With rising demand for vaccines, biologics, and specialty drugs, maintaining strict temperature controls is critical for preventing degradation. Advanced refrigerant technologies ensure safe transport and storage, supporting the growth of biologics and personalized medicine. Government regulations enforcing stringent temperature maintenance further drive the market demand. The expansion of pharmaceutical supply chains, particularly in emerging economies, fuels adoption of effective refrigerant solutions.
Complexity of regulatory compliance
Strict regulatory frameworks govern the transportation and storage of temperature-sensitive pharmaceuticals, creating compliance challenges for manufacturers. Companies must adhere to stringent global standards set by organizations such as the FDA and WHO, which often require significant documentation and validation. Meeting diverse regional regulations increases operational complexity, impacting logistics and supply chain efficiency. Non-compliance can lead to product recalls, legal consequences, and financial losses, deterring market growth.
Global expansion of e-commerce and online grocery services
Consumers increasingly order perishable goods, including frozen foods, dairy, and fresh produce, necessitating effective cooling solutions during transportation. Retailers and logistics providers are incorporating advanced refrigerants to ensure product quality and safety in last-mile deliveries. The growth of direct-to-consumer pharmaceutical shipments further amplifies refrigerant adoption across healthcare logistics. Technological advancements in packaging materials and refrigerants support sustainable and efficient cooling methods for global e-commerce expansion.
Supply chain disruptions and temperature excursions
Transportation delays, labor shortages, and geopolitical tensions can compromise temperature-controlled shipments, leading to product losses. Temperature excursions caused by inadequate cooling or unexpected environmental conditions pose threats to pharmaceutical and perishable goods quality. Rising costs of raw materials and energy consumption also challenge refrigerant market stability. Companies must invest in robust monitoring systems and predictive analytics to mitigate these risks and ensure regulatory compliance.
Covid-19 Impact
The COVID-19 pandemic significantly influenced the Cold Chain Packaging Refrigerants Market, reshaping logistics and supply chain priorities. The urgent global vaccine rollout heightened demand for efficient refrigerant solutions to preserve pharmaceutical stability during transportation. Supply chain disruptions, including labour shortages and logistics constraints, affected refrigerant availability and pricing. Post-pandemic, the growing reliance on telemedicine and direct-to-consumer pharmaceutical deliveries continues to drive demand.
The gel packs segment is expected to be the largest during the forecast period
The gel packs segment is expected to account for the largest market share during the forecast period, due to its versatility and efficiency in temperature maintenance. Gel packs offer consistent cooling for pharmaceuticals, food products, and biological samples, making them a preferred choice in cold chain logistics. Their ease of use and reusability enhance sustainability and reduce overall packaging costs. Advances in phase change materials have further improved gel pack performance, optimizing cooling duration and stability.
The diagnostic laboratories segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the diagnostic laboratories segment is predicted to witness the highest growth rate, due to the increasing demand for temperature-sensitive diagnostic materials. Blood samples, reagents, and testing kits require strict temperature control to maintain their integrity during transportation. Rising prevalence of infectious diseases and advancements in diagnostic technologies fuel demand for specialized refrigerant solutions. The expansion of laboratory networks and healthcare testing facilities worldwide further drives market growth.
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to the rapid expansion of pharmaceutical and food industries. Countries like China, India, and Japan are investing heavily in cold chain infrastructure to support growing healthcare and retail demands. Increasing consumer preference for fresh and frozen food products drives widespread adoption of efficient refrigerant solutions. Government regulations mandating stringent temperature maintenance for pharmaceuticals further propel market growth.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to the region's advanced healthcare and food supply chain infrastructure. Stringent regulations governing pharmaceutical storage and transportation drive significant refrigerant adoption. Technological innovations in refrigerant materials and monitoring systems enhance cold chain efficiency and reliability. Expanding e-commerce operations, particularly in grocery and pharmaceutical delivery sectors, fuel market growth.
Key players in the market
Some of the key players profiled in the Cold Chain Packaging Refrigerants Market include Cold Chain Technologies, Peli BioThermal, Sonoco ThermoSafe, Nordic Cold Chain Solutions, Cryopak, CSafe, Softbox Systems, Sealed Air Corporation, Intelsius, Sofrigam, Tempack, Orora Group, Chill-Pak, Coolpac, and Blowkings.
In December 2024, Sonoco Products Company announced it has entered into an agreement to sell its Thermoformed and Flexibles Packaging business ("TFP") to TOPPAN Holdings Inc. ("Toppan") for approximately $1.8 billion on a cash-free and debt-free basis and subject to customary adjustments (the "Transaction").
In March 2025, Cold Chain Technologies (CCT) has acquired Global Cold Chain Solutions, expanding its Asia Pacific presence & capabilities. Cold Chain Technologies ("CCT") and digital monitoring solutions for the transportation of temperature-sensitive life sciences products, today announced it has acquired Global Cold Chain Solutions ("GCCS"), a leading provider of passive cold chain solutions primarily in Australia and India. Terms of the transaction were not disclosed.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.